AD
The role of microRNA-485 in neurodegenerative disease
Reviews in the Neurosciences, 07 Jul 2022
Publications
Publications
AD
Innate Immunity and Cell Death in Alzheimer's Disease
American Society for Neurochemistry, 20 Oct 2021
AD Biomarker
miRNAs as Therapeutic Tools in Alzheimer’s Disease
International Journal of Molecular Sciences, 01 Dec 2021
AD Biomarker
Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression
International Journal of Molecular Sciences, 04 Dec 2021
AD Biomarker
MicroRNAs as a Diagnostic Biomarker in Alzheimer’s Disease: Potential Roles and Characteristics
Global journal of intellectual & developmental disabilities, 14 Sep 2021
mRNA Vaccine
Influenza Viruses: Innate Immunity and mRNA Vaccines
Frontiers in Immunology, 31 Aug 2021
Diagnosis
Diagnostic and therapeutic biomarkers for Alzheimer’s disease in human‑derived platelets
Genes & Genomics, 12 Dec 2020
Posters & Presentations
Presentation
Role of miRNA in Neurodegenerative Disease
2022 The Korean Society Nonclinical Study (KSNS) / October, 2022
Presentation
Efficacy study and brain delivery in animal models of neurodegenerative disease (Rodent and NHP)
RNA Leaders World Congress / October, 2022
Presentation
Overcoming the Blood Brain Barrier for RNA therapeutics
2022 KoNECT-MOHW-MFDS INTERNATIONAL CONFERENCE / October, 2022
Poster
BMD-001, a nanoparticle containing miR-485-3p antisense oligonucleotide, blocks Alzheimer’s disease progression
Alzheimer’s Association International Conference (AAIC) / July, 2022
Presentation
Overcoming the Blood–Brain Barrier for RNA therapeutics
RNA Leaders World Congress / March, 2022